https://www.selleckchem.com/pr....oducts/trastuzumab-d
Incorrectly assuming that the measurement bias is constant leads to 95% confidence intervals for the treatment effect with reduced coverage (95%); the coverage is especially reduced when the quantitative imaging biomarker measurements have good precision and/or there is a large treatment effect. Estimates of the measurement bias from technical performance validation studies can be used to correct the confidence intervals for the treatment effect. Technical performance validation studies of quantitative imaging biomark
Like
Comment
Share
